Long COVID Neurological and Psychiatric Prevalence Statistics 2021-2024

Global prevalence data from 2021-2024 consolidates statistics on neurological and psychiatric symptoms in Long COVID. Key figures include brain fog prevalence of 32-60%, fatigue at 74%, and anxiety ranging from 23-44%. The dataset includes longitudinal data from Bangladesh and multi-country comparisons from the OECD.

Use Cases

• Analyze longitudinal trends in fatigue prevalence using data from Bangladesh showing 82.9% at onset and 16.1% at 31 weeks.
• Compare country-level brain fog prevalence rates, such as the 60% figure reported for Colombia, against global ranges of 32-60%.
• Model the relationship between post-COVID neuroinflammatory mechanisms and reported symptom duration across different patient cohorts.
• Investigate the correlation between risk factors and the reported 41-64% prevalence range for sleep disorders in Long COVID patients.

Strengths

• Provides specific prevalence percentages for key symptoms like brain fog (32-60%), fatigue (74%), and anxiety (23-44%).
• Includes longitudinal data tracking symptom change over time, such as fatigue dropping from 82.9% to 16.1% over 31 weeks in Bangladesh.
• Covers a global scope with country-level statistics and multi-country comparisons from the OECD.

Limitations

• The dataset's underlying sample sizes and methodologies for each prevalence figure are not specified, limiting reproducibility.
• Data is aggregated from various sources, which may introduce heterogeneity in measurement and reporting standards.
• Temporal coverage ends in 2024, potentially missing more recent developments in Long COVID research.

Provenance

Source

Juan Moises de la Serna Dataverse

Collection Method

Consolidation of global and country-level statistics from various studies.

Time Range

2021-2024

Freshness

Last updated in March 2026.

Geography

Global, with specific data from countries including Bangladesh, Colombia, the US, and OECD nations.